Drugs / NT-501 ECT
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02862938 | Jun 2016 → Aug 2025 overdue | glaucoma | Stanford University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NT-501 ECT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02862938 ↗ |
| Route | Intravitreal | “intravitreal implantation” NCT02862938 ↗ |